TABLE 1 .
Treatment | Gel formation at AnxA5 concn (µg/ml) of: |
|||||||
---|---|---|---|---|---|---|---|---|
0 | 0.0001 | 0.001 | 0.01 | 0.1 | 1 | 5 | 10 | |
AnxA5 + 0.05 ng/ml LPSa in HBS containing 5 mM CaCl2 | + | + | + | − | − | − | − | − |
LPS at 1 ng/ml = 5 EU.
Treatment | Gel formation at AnxA5 concn (µg/ml) of: |
|||||||
---|---|---|---|---|---|---|---|---|
0 | 0.0001 | 0.001 | 0.01 | 0.1 | 1 | 5 | 10 | |
AnxA5 + 0.05 ng/ml LPSa in HBS containing 5 mM CaCl2 | + | + | + | − | − | − | − | − |
LPS at 1 ng/ml = 5 EU.